These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 5772134

  • 1. [On the mechanism of potentiation of hexenal narcosis by ortho-tolylhydrazide of diethylglycolic acid].
    Bargteĭl BA, Kolla VE.
    Farmakol Toksikol; 1969; 32(2):141-3. PubMed ID: 5772134
    [No Abstract] [Full Text] [Related]

  • 2. [On the mechanism of potentiation of hypnotic action of hexenal by chlorazicin].
    Vikhliaev IuI, Avakumov VM.
    Farmakol Toksikol; 1966; 29(5):515-8. PubMed ID: 5997313
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [To the study of the mechanism of potentiation of hypnotic effect of hexenal by 3,5-dimethyl-4-brompyrazol].
    Avakumov VM, Batulin IuM.
    Farmakol Toksikol; 1968; 31(4):402-5. PubMed ID: 5698126
    [No Abstract] [Full Text] [Related]

  • 5. Studies on some possible mechanisms of potentiation of hexobarbital hypnosis by pilocarpine, muscarine and arecoline.
    Tsujimoto A, Doi T, Ikeda M, Nishikawa T.
    Arch Int Pharmacodyn Ther; 1974 Dec; 212(2):264-73. PubMed ID: 4447408
    [No Abstract] [Full Text] [Related]

  • 6. Cannabis-induced potentiation of hexobarbitone hypnosis in mice: role of brain monoamines.
    Ghosh P, Bhattacharya SK.
    Indian J Exp Biol; 1979 Dec; 17(12):1387-9. PubMed ID: 540990
    [No Abstract] [Full Text] [Related]

  • 7. Hexobarbitone response in barbitone-dependent and withdrawn rats.
    Stevenson IH, Turnbull MJ.
    Br J Pharmacol; 1968 Sep; 34(1):210P-211P. PubMed ID: 5692083
    [No Abstract] [Full Text] [Related]

  • 8. [Effect of acetone on barbiturate narcosis].
    Postolache V, Safta L, Cuparencu B, Steiner L.
    Arch Toxikol; 1969 Sep; 24(3):333-7. PubMed ID: 5360668
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Influence of hormones on hexobarbital narcosis of rats].
    Hempel R.
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968 Sep; 259(5):413-8. PubMed ID: 4236496
    [No Abstract] [Full Text] [Related]

  • 11. The potentiation of barbiturates by desipramine in the mouse: mechanism of action.
    Shah HC, Lal H.
    J Pharmacol Exp Ther; 1971 Nov; 179(2):404-9. PubMed ID: 5133609
    [No Abstract] [Full Text] [Related]

  • 12. Effect of exposure to lindane on drug metabolism: decreased hexobarbital sleeping-times and increased antipyrine disappearance rate in rats.
    Kolmodin-Hedman B, Alexanderson B, Sjöqvist F.
    Toxicol Appl Pharmacol; 1971 Nov; 20(3):299-307. PubMed ID: 4109017
    [No Abstract] [Full Text] [Related]

  • 13. [Effect of sodium salts of levorin and nystatin on some liver functions in experiment].
    Iarobkova ND.
    Antibiotiki; 1970 Oct; 15(10):912-6. PubMed ID: 5487856
    [No Abstract] [Full Text] [Related]

  • 14. [Effect of some derivatives of hydrazine on the activity of 5-oxyryptophan decarboxylase in experiments in vivo].
    Mikhaĭlova TV, Chizhikova VG, Gilev AP.
    Farmakol Toksikol; 1969 Oct; 32(2):180-3. PubMed ID: 5772145
    [No Abstract] [Full Text] [Related]

  • 15. Anaesthesia-like condition and/or potentiation of hexobarbital sleep produced by pungent agents in normal and capsaicin-desensitized rats.
    Jancsó-Gabor A.
    Acta Physiol Acad Sci Hung; 1980 Oct; 55(1):57-62. PubMed ID: 7395532
    [Abstract] [Full Text] [Related]

  • 16. Cannabinoids and hexobarbital induced loss of righting reflexes.
    Fernandes M, Kluwe S, Coper H.
    Naunyn Schmiedebergs Arch Pharmacol; 1974 Oct; 283(4):431-5. PubMed ID: 4278425
    [No Abstract] [Full Text] [Related]

  • 17. [Half-life of hexobarbital and zoxazolamine in rodents. 2-In the rat].
    Buchel L, Absil J, Murawsky M.
    C R Seances Soc Biol Fil; 1974 Oct; 168(2-3):265-70. PubMed ID: 4282286
    [No Abstract] [Full Text] [Related]

  • 18. Potentiation of cardiovascular responses to hydralazine by diverse hydrazine derivatives.
    Vidrio H.
    J Pharmacol Exp Ther; 1994 Oct; 271(1):171-5. PubMed ID: 7965711
    [Abstract] [Full Text] [Related]

  • 19. [Mechanism of pantogam potentiation of certain effects of hexobarbital and sodium barbital and inhibition of phenamine hyperactivity].
    Avakumov VM, Kovler MA.
    Farmakol Toksikol; 1981 Oct; 44(1):30-4. PubMed ID: 7262297
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of drug metabolism by fluoxetine.
    Fuller RW, Rathbun RC, Parli CJ.
    Res Commun Chem Pathol Pharmacol; 1976 Feb; 13(2):353-6. PubMed ID: 943818
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.